Three Immune-Related Prognostic mRNAs as Therapeutic Targets for Pancreatic Cancer

Frontiers in Medicine

Haibo Liu¹  Hui Feng¹  Fan Niu¹  Pengcheng He¹  Yi Liu¹  Yueji Zou²  Cangang Zhang³  Yanan Zhu⁴ 

[1] Department of Hematology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China;Department of Imaging, Penglai Traditional Chinese Medicine Hospital, Penglai, China;Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, China;Jiangsu ALF Biotechnology Co., Ltd., Nanjing, China;

关键词: pancreatic cancer;    met;    OAS1;    OASL;    therapeutic targets;    prognosis;   

DOI  :  10.3389/fmed.2021.649326

来源: Frontiers

【 授权许可】

CC BY